Skin aging is an intricate process influenced by various factors, with the carbonylation of skin proteins emerging as a key contributor to the unwelcome phenomenon of skin yellowing.

The nutraceuticals industry is experiencing rapid growth, set to reach $174.89 billion by 2024, driven by factors like increasing health consciousness and demographic shifts. This growth is reshaping distribution channels and consumer access to nutraceuticals, making adaptation crucial for distribution pharma.

JMC, a leading manufacturer in saccharin and sulfur-based fine chemicals, is at the forefront of providing sodium saccharin, a safe artificial sweetener with remarkable purity and versatility, meeting various quality standards, and catering to pharmaceutical and other applications.

The article explores the changing role of excipients in Europe's pharmaceutical industry, driven by regulatory changes, innovations, sustainability, and more, offering opportunities for pharmaceutical distributors.

In the realm of pharmaceuticals, DKSH Pharmaceutical Italy is a distinguished name known for its unwavering commitment to quality, innovation, and top-tier pharmaceutical ingredients, catering to diverse industrial applications and setting industry standards.